From the publishers of The New England Journal of Medicine

Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.

  1. Home>
  2. Specialties>
  3. General Medicine>
  4. Summary and Comment

Spot Morning Urine Protein to Creatinine Ratio -- A Better Way to Predict Renal Failure.

The measurement of proteinuria may help predict the outcome of renal disease. The spot morning protein-to-creatinine ratio is an efficient predictor of protein excretion in patients with diabetic nephropathy; these Italian investigators tested its predictive value for patients with nondiabetic renal disease.

In 177 patients with nondiabetic renal disease and persistent proteinuria, 24-hour urinary protein was found to correlate well with spot morning urine protein-to-creatinine ratios. In further follow-up of a subgroup of 98 patients, decline in renal function was significantly correlated with the protein-to-creatinine ratio: at 12 months, kidney survival (i.e., lack of progression to end-stage renal disease) was greater than 95 percent with a ratio below 1.7, 87.5 percent with a ratio of 1.7 to 2.7, and 78.8 percent with a ratio greater than 2.7. In fact, the spot morning protein-to-creatinine ratio was more predictive of disease progression than was 24-hour urine protein excretion.

Comment: Although the study numbers were not large, the data were impressive. With its ease of use, low cost, and apparent accuracy, the spot morning urine protein-to-creatinine ratio deserves more attention as a prognostic indicator in patients with nondiabetic renal disease.

— KI Marton

Published in Journal Watch General Medicine March 10, 1998

Citation(s):

Ruggenenti P et al. Cross sectional longitudinal study of spot morning urine protein: creatinine ratio, 24-hour urine protein excretion rate, glomerular filtration rate, and end stage renal failure in chronic renal disease in patients without diabetes. BMJ 1998 Feb 14 316 504-509.

Your Remark:

Reader Remarks are intended to encourage lively discussion of clinical topics with your peers in the medical community. Please consider this when composing your remark.

Fields marked with an * are required.

Name as you'd like it to appear:

Submitting a comment indicates you have read and agreed to the remark guidelines and declare:*

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

 

CLEAR erases anything you've added in any part of the form. CONTINUE allows you to check your entire post (and edit it if necessary) before submitting.

To ensure that your Reader Remark is not formatted as one long paragraph, precede new paragraphs with either a blank line or an indentation.

Search

Advanced

Article Tools

Reader Remarks

Sign-In

Forgot your password?

New to Journal Watch?

E-mail Alerts

Delivered to your inbox.
Tailored to your interests. Free.

Sign Up Now!

Journal Watch Newsletters

Available in 13 specialties with convenient delivery and 10 free online CME exams.

Subscribe Now!

Copyright © 1998. Massachusetts Medical Society. All rights reserved.